The import of medicaments mixed together for therapeutic use to Indonesia has shown varied trends over the past decade. In 2023, the import value stood at 29.204 million US Dollars. This represents a year-on-year increase of 3.1% from the previous year. Looking at the long-term trends, the Compound Annual Growth Rate (CAGR) over the past five years, from 2019 to 2023, has been 3.8%. The upcoming five years, from 2024 to 2028, are forecasted to exhibit a relatively modest growth, with a forecasted 5-year CAGR of 2.05% and an overall growth rate of 10.67%.

Future trends to watch for:

The influence of regulatory changes in Indonesia's healthcare sector impacting import volumes.
Geopolitical and economic fluctuations affecting trade and import dynamics.
Technology advancements and shifts towards personalized medicine possibly altering import requirements.